Top Abstract Purchase Related
Home
>
Node
>
Subnode

UFT/leucovorin in advanced squamous cell carcinoma of the head and neck administered with radiotherapy

Mercke, C.

Oncology 14(10 Suppl 9: 79-81

2000

ISSN/ISBN: 0890-9091
PMID: 11098501
Document Number: 524297
This is an open-label, nonrandomized phase I study to determine the maximum tolerated dose and dose-limiting toxicity of UFT plus leucovorin when given concomitantly with hyperfractionated radiotherapy in patients with head and neck cancer. The study period is determined by the course of radiotherapy, which is given as 1.7 Gy per fraction twice daily for 5 days (Monday to Friday) in 2 consecutive weeks, followed by 1 week of rest, and subsequently another 2 weeks of radiotherapy (Monday to Friday plus Monday to Thursday). Total duration of therapy will be 5 weeks.

Document emailed within 1 workday
Secure & encrypted payments

Kamnerdsupaphon, P.; Chitapanarux, I.; Lorvidhaya, V.; Sumitsawan, Y.; Tharavichitkul, E.; Sukthomya, V. 2008: Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(11): 1869-1873
Berthelsen, A.; Nielsen, E.S.; Rygård, J. 1986: Cytostatic treatment of advanced squamous cell carcinoma of the head and neck Ugeskrift for Laeger 148(33): 2074-2080
Stathopoulos, G.; Wiltshaw, E.; Price, L.A. 1976: Quadruple chemotherapy in advanced squamous cell carcinoma of the head and neck British Journal of Clinical Practice 30(10): 188-189
Tatarek, R.; Merlano, M.; Rosso, R.; Corvò, L. 1984: Combined radiotherapy and CMF-B cytotoxic regimen in stage III-IV head and neck squamous cell carcinoma Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(5): 330-332
Rosenthal, D.I.; Sinard, R.J.; Okani, O.; Corak, J.; Kavanaugh, D.; Kamen, B.; Vuitch, F.M.; Gazdar, A.F.; Griener, J.; Frenkel, E.P.; Carbone, D.P. 1997: Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase i study Seminars in Oncology 24(6 Suppl 19: S19
Corvò, R.; Margarino, G.; Sanguineti, G.; Geido, E.; Scala, M.; Mereu, P.; Cavallari, M.; Bonanno, S.; Garaventa, G.; Barbieri, M.; Giaretti, W. 2000: Cell kinetics analysis in patients affected by squamous cell carcinoma of the head and neck treated with primary surgery and adjuvant radiotherapy Tumori 86(1): 53-58
Corvò, R.; Foppiano, F.; Bacigalupo, A.; Berretta, L.; Benasso, M.; Vitale, V. 2004: Contralateral parotid-sparing radiotherapy in patients with unilateral squamous cell carcinoma of the head and neck: technical methodology and preliminary results Tumori 90(1): 66-72
Adamiak, G.; Ligeziński, A.; Jurkiewicz, D.; Hermanowski, M.; Konieczna, M.; Rapiejko, P. 2000: Squamous cell carcinoma antigen (Scc-Ag): diagnostic utility in squamous cell carcinoma antigen of the head and neck with metastasis to lymph nodes Otolaryngologia Polska 54(Suppl 31): 203-205
Livingston, R.B.; Einhorn, L.H.; Burgess, M.A.; Gottlieb, J.A. 1976: Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck Cancer Treatment Reports 60(1): 103-105
Bender, M.D.; Montgomery, A.C.; Shaw, H.J. 1985: Radical neck dissection for squamous cell carcinoma of the head and neck: early and long-term results of treatment Annals of the Royal College of Surgeons of England 67(1): 47-50
Vogl, S.E.; Camacho, F.J.; Kaplan, B.H.; O'Donnell, M.R. 1984: Phase Ii trial of vindesine in advanced squamous cell cancer of the head and neck Cancer Treatment Reports 68(3): 559-560
Hato, N.; Yumoto, E.; Hyodo, M.; Hinohira, Y.; Kawamura, T.; Fujii, T. 1998: Radiotherapy combined with daily administration of low-dose cisplatin for squamous cell carcinomas of the head and neck Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(10): 1533-1537
Voravud, N.; Charuruks, N.; Mutirangura, A. 1997: Squamous cell carcinoma of head and neck Journal of the Medical Association of Thailand 80(4): 207-218
Greenberg, B.R. 1985: Chemotherapy of squamous cell carcinoma of the head and neck Arizona Medicine 42(7): 411-417
Mayer, A.; Andratschke, M.; Pauli, C.; Graefe, H.; Kristina, K.; Wollenberg, B. 2005: Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck Anticancer Research 25(6b): 4075-4080
Caignard, A.; Dietrich, P.Y.; Morand, V.; Lim, A.; Pannetier, C.; Leridant, A.M.; Hercend, T.; Even, J.; Kourilsky, P.; Triebel, F. 1994: Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck Cancer Research 54(5): 1292-1297
Cada, Z.; Boucek, J.; Dvoranková, B.; Chovanec, M.; Plzák, J.; Kodets, R.; Betka, J.; Pinot, G.L.; Gabius, H-Joachim.; Smetana, K. 2007: Nucleostemin expression in squamous cell carcinoma of the head and neck Anticancer Research 27(5a): 3279-3284
Poovaneswaran, S.; Paleri, V.; Charlton, F.; Dobrowsky, W.; Kelly, C. 2012: Cutaneous metastases from head and neck squamous cell carcinoma Medical Journal of Malaysia 67(4): 430-432
Kakurina, G.V.; Kondakova, I.V.; Choĭnzonov, E.L. 2012: Prognosis for the metastasis of squamous cell carcinoma of the head and neck Voprosy Onkologii 58(1): 26-32
Wagenblast, J.; Hambek, M.; Baghi, M.; Knecht, R. 2008: Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines Anticancer Research 28(2a): 687-692